Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
49
VMD Quote, Financials, Valuation and Earnings
Last price:
$7.41
Seasonality move
:
6.43%
Day range:
$7.40 - $7.68
52-week range:
$5.93 - $8.62
Dividend yield:
0%
P/E ratio:
22.81x
P/S ratio:
1.22x
P/B ratio:
2.15x
Volume:
153K
Avg. volume:
150.3K
1-year change:
-7.26%
Market cap:
$286.7M
Revenue:
$224.3M
EPS (TTM):
$0.33
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
VMD
Viemed Healthcare, Inc.
|
$72M | $0.10 | 27.85% | 25% | $13.00 |
|
ELMD
Electromed, Inc.
|
$16.6M | -- | 11.04% | -- | $36.00 |
|
IRIX
IRIDEX Corp.
|
$12.8M | -$0.12 | -2.72% | -18.18% | -- |
|
MYO
Myomo, Inc.
|
$9.4M | -$0.11 | -13.8% | -1168.66% | $5.00 |
|
PAHC
Phibro Animal Health Corp.
|
$345.4M | $0.60 | 15% | 756.68% | $43.00 |
|
STXS
Stereotaxis, Inc.
|
$8.4M | -$0.06 | 43.53% | -30.79% | $4.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
VMD
Viemed Healthcare, Inc.
|
$7.54 | $13.00 | $286.7M | 22.81x | $0.00 | 0% | 1.22x |
|
ELMD
Electromed, Inc.
|
$29.93 | $36.00 | $249.6M | 32.20x | $0.00 | 0% | 3.99x |
|
IRIX
IRIDEX Corp.
|
$0.97 | -- | $16.7M | -- | $0.00 | 0% | 0.32x |
|
MYO
Myomo, Inc.
|
$0.90 | $5.00 | $34.6M | -- | $0.00 | 0% | 0.89x |
|
PAHC
Phibro Animal Health Corp.
|
$40.41 | $43.00 | $1.6B | 24.30x | $0.12 | 1.19% | 1.18x |
|
STXS
Stereotaxis, Inc.
|
$2.32 | $4.20 | $216.5M | -- | $0.00 | 0% | 6.84x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
VMD
Viemed Healthcare, Inc.
|
15.6% | 0.440 | 9.5% | 0.87x |
|
ELMD
Electromed, Inc.
|
-- | 1.217 | -- | 4.58x |
|
IRIX
IRIDEX Corp.
|
50.55% | 0.834 | 18.81% | 1.03x |
|
MYO
Myomo, Inc.
|
45.68% | -2.855 | 35.87% | 1.94x |
|
PAHC
Phibro Animal Health Corp.
|
71.58% | 2.736 | 47.87% | 1.12x |
|
STXS
Stereotaxis, Inc.
|
32.62% | 1.831 | 1.93% | 0.81x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
VMD
Viemed Healthcare, Inc.
|
$40.9M | $7M | 9.63% | 10.37% | 9.69% | $10.7M |
|
ELMD
Electromed, Inc.
|
$13.2M | $2.7M | 18.88% | 18.89% | 15.81% | -$98K |
|
IRIX
IRIDEX Corp.
|
$4M | -$1.4M | -54.1% | -155.93% | -11.3% | -$1.2M |
|
MYO
Myomo, Inc.
|
$6.4M | -$3.5M | -46.49% | -68.35% | -34.86% | -$2.9M |
|
PAHC
Phibro Animal Health Corp.
|
$119.3M | $47.9M | 6.8% | 24.77% | 13.16% | -$4.5M |
|
STXS
Stereotaxis, Inc.
|
$4.1M | -$5.2M | -141.59% | -218.3% | -69.75% | -$4.2M |
Viemed Healthcare, Inc. vs. Competitors
-
Which has Higher Returns VMD or ELMD?
Electromed, Inc. has a net margin of 5.01% compared to Viemed Healthcare, Inc.'s net margin of 12.65%. Viemed Healthcare, Inc.'s return on equity of 10.37% beat Electromed, Inc.'s return on equity of 18.89%.
Company Gross Margin Earnings Per Share Invested Capital VMDViemed Healthcare, Inc.56.94% $0.09 $160.2M ELMDElectromed, Inc.78.15% $0.25 $44.7M -
What do Analysts Say About VMD or ELMD?
Viemed Healthcare, Inc. has a consensus price target of $13.00, signalling upside risk potential of 72.41%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 20.28%. Given that Viemed Healthcare, Inc. has higher upside potential than Electromed, Inc., analysts believe Viemed Healthcare, Inc. is more attractive than Electromed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings VMDViemed Healthcare, Inc.2 0 0 ELMDElectromed, Inc.4 0 0 -
Is VMD or ELMD More Risky?
Viemed Healthcare, Inc. has a beta of 1.206, which suggesting that the stock is 20.563% more volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.
-
Which is a Better Dividend Stock VMD or ELMD?
Viemed Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Viemed Healthcare, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VMD or ELMD?
Viemed Healthcare, Inc. quarterly revenues are $71.9M, which are larger than Electromed, Inc. quarterly revenues of $16.9M. Viemed Healthcare, Inc.'s net income of $3.6M is higher than Electromed, Inc.'s net income of $2.1M. Notably, Viemed Healthcare, Inc.'s price-to-earnings ratio is 22.81x while Electromed, Inc.'s PE ratio is 32.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Viemed Healthcare, Inc. is 1.22x versus 3.99x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VMDViemed Healthcare, Inc.1.22x 22.81x $71.9M $3.6M ELMDElectromed, Inc.3.99x 32.20x $16.9M $2.1M
-
Which has Higher Returns VMD or IRIX?
IRIDEX Corp. has a net margin of 5.01% compared to Viemed Healthcare, Inc.'s net margin of -12.6%. Viemed Healthcare, Inc.'s return on equity of 10.37% beat IRIDEX Corp.'s return on equity of -155.93%.
Company Gross Margin Earnings Per Share Invested Capital VMDViemed Healthcare, Inc.56.94% $0.09 $160.2M IRIXIRIDEX Corp.32.15% -$0.09 $9.5M -
What do Analysts Say About VMD or IRIX?
Viemed Healthcare, Inc. has a consensus price target of $13.00, signalling upside risk potential of 72.41%. On the other hand IRIDEX Corp. has an analysts' consensus of -- which suggests that it could grow by 106.19%. Given that IRIDEX Corp. has higher upside potential than Viemed Healthcare, Inc., analysts believe IRIDEX Corp. is more attractive than Viemed Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings VMDViemed Healthcare, Inc.2 0 0 IRIXIRIDEX Corp.0 0 0 -
Is VMD or IRIX More Risky?
Viemed Healthcare, Inc. has a beta of 1.206, which suggesting that the stock is 20.563% more volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.652, suggesting its less volatile than the S&P 500 by 34.842%.
-
Which is a Better Dividend Stock VMD or IRIX?
Viemed Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Viemed Healthcare, Inc. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VMD or IRIX?
Viemed Healthcare, Inc. quarterly revenues are $71.9M, which are larger than IRIDEX Corp. quarterly revenues of $12.5M. Viemed Healthcare, Inc.'s net income of $3.6M is higher than IRIDEX Corp.'s net income of -$1.6M. Notably, Viemed Healthcare, Inc.'s price-to-earnings ratio is 22.81x while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Viemed Healthcare, Inc. is 1.22x versus 0.32x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VMDViemed Healthcare, Inc.1.22x 22.81x $71.9M $3.6M IRIXIRIDEX Corp.0.32x -- $12.5M -$1.6M
-
Which has Higher Returns VMD or MYO?
Myomo, Inc. has a net margin of 5.01% compared to Viemed Healthcare, Inc.'s net margin of -36.3%. Viemed Healthcare, Inc.'s return on equity of 10.37% beat Myomo, Inc.'s return on equity of -68.35%.
Company Gross Margin Earnings Per Share Invested Capital VMDViemed Healthcare, Inc.56.94% $0.09 $160.2M MYOMyomo, Inc.63.84% -$0.09 $26.9M -
What do Analysts Say About VMD or MYO?
Viemed Healthcare, Inc. has a consensus price target of $13.00, signalling upside risk potential of 72.41%. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 454.94%. Given that Myomo, Inc. has higher upside potential than Viemed Healthcare, Inc., analysts believe Myomo, Inc. is more attractive than Viemed Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings VMDViemed Healthcare, Inc.2 0 0 MYOMyomo, Inc.4 0 0 -
Is VMD or MYO More Risky?
Viemed Healthcare, Inc. has a beta of 1.206, which suggesting that the stock is 20.563% more volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.026, suggesting its more volatile than the S&P 500 by 2.583%.
-
Which is a Better Dividend Stock VMD or MYO?
Viemed Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Viemed Healthcare, Inc. pays -- of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VMD or MYO?
Viemed Healthcare, Inc. quarterly revenues are $71.9M, which are larger than Myomo, Inc. quarterly revenues of $10.1M. Viemed Healthcare, Inc.'s net income of $3.6M is higher than Myomo, Inc.'s net income of -$3.7M. Notably, Viemed Healthcare, Inc.'s price-to-earnings ratio is 22.81x while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Viemed Healthcare, Inc. is 1.22x versus 0.89x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VMDViemed Healthcare, Inc.1.22x 22.81x $71.9M $3.6M MYOMyomo, Inc.0.89x -- $10.1M -$3.7M
-
Which has Higher Returns VMD or PAHC?
Phibro Animal Health Corp. has a net margin of 5.01% compared to Viemed Healthcare, Inc.'s net margin of 7.29%. Viemed Healthcare, Inc.'s return on equity of 10.37% beat Phibro Animal Health Corp.'s return on equity of 24.77%.
Company Gross Margin Earnings Per Share Invested Capital VMDViemed Healthcare, Inc.56.94% $0.09 $160.2M PAHCPhibro Animal Health Corp.32.8% $0.65 $1.1B -
What do Analysts Say About VMD or PAHC?
Viemed Healthcare, Inc. has a consensus price target of $13.00, signalling upside risk potential of 72.41%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 6.41%. Given that Viemed Healthcare, Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe Viemed Healthcare, Inc. is more attractive than Phibro Animal Health Corp..
Company Buy Ratings Hold Ratings Sell Ratings VMDViemed Healthcare, Inc.2 0 0 PAHCPhibro Animal Health Corp.0 2 0 -
Is VMD or PAHC More Risky?
Viemed Healthcare, Inc. has a beta of 1.206, which suggesting that the stock is 20.563% more volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.
-
Which is a Better Dividend Stock VMD or PAHC?
Viemed Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.19% to investors and pays a quarterly dividend of $0.12 per share. Viemed Healthcare, Inc. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios VMD or PAHC?
Viemed Healthcare, Inc. quarterly revenues are $71.9M, which are smaller than Phibro Animal Health Corp. quarterly revenues of $363.9M. Viemed Healthcare, Inc.'s net income of $3.6M is lower than Phibro Animal Health Corp.'s net income of $26.5M. Notably, Viemed Healthcare, Inc.'s price-to-earnings ratio is 22.81x while Phibro Animal Health Corp.'s PE ratio is 24.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Viemed Healthcare, Inc. is 1.22x versus 1.18x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VMDViemed Healthcare, Inc.1.22x 22.81x $71.9M $3.6M PAHCPhibro Animal Health Corp.1.18x 24.30x $363.9M $26.5M
-
Which has Higher Returns VMD or STXS?
Stereotaxis, Inc. has a net margin of 5.01% compared to Viemed Healthcare, Inc.'s net margin of -86.59%. Viemed Healthcare, Inc.'s return on equity of 10.37% beat Stereotaxis, Inc.'s return on equity of -218.3%.
Company Gross Margin Earnings Per Share Invested Capital VMDViemed Healthcare, Inc.56.94% $0.09 $160.2M STXSStereotaxis, Inc.54.94% -$0.07 $17.1M -
What do Analysts Say About VMD or STXS?
Viemed Healthcare, Inc. has a consensus price target of $13.00, signalling upside risk potential of 72.41%. On the other hand Stereotaxis, Inc. has an analysts' consensus of $4.20 which suggests that it could grow by 81.04%. Given that Stereotaxis, Inc. has higher upside potential than Viemed Healthcare, Inc., analysts believe Stereotaxis, Inc. is more attractive than Viemed Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings VMDViemed Healthcare, Inc.2 0 0 STXSStereotaxis, Inc.3 0 0 -
Is VMD or STXS More Risky?
Viemed Healthcare, Inc. has a beta of 1.206, which suggesting that the stock is 20.563% more volatile than S&P 500. In comparison Stereotaxis, Inc. has a beta of 1.472, suggesting its more volatile than the S&P 500 by 47.244%.
-
Which is a Better Dividend Stock VMD or STXS?
Viemed Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Viemed Healthcare, Inc. pays -- of its earnings as a dividend. Stereotaxis, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VMD or STXS?
Viemed Healthcare, Inc. quarterly revenues are $71.9M, which are larger than Stereotaxis, Inc. quarterly revenues of $7.5M. Viemed Healthcare, Inc.'s net income of $3.6M is higher than Stereotaxis, Inc.'s net income of -$6.5M. Notably, Viemed Healthcare, Inc.'s price-to-earnings ratio is 22.81x while Stereotaxis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Viemed Healthcare, Inc. is 1.22x versus 6.84x for Stereotaxis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VMDViemed Healthcare, Inc.1.22x 22.81x $71.9M $3.6M STXSStereotaxis, Inc.6.84x -- $7.5M -$6.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
55
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
35
SMX alert for Dec 19
SMX (Security Matters) Plc [SMX] is up 11.91% over the past day.
Sell
36
INSP alert for Dec 19
Inspire Medical Systems, Inc. [INSP] is up 1.39% over the past day.
Sell
40
INSM alert for Dec 19
Insmed, Inc. [INSM] is up 4.79% over the past day.
